Page last updated: 2024-10-30

mecamylamine and Ischemic Attack, Transient

mecamylamine has been researched along with Ischemic Attack, Transient in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwon, H1
Jung, JW1
Lee, YC1
Ryu, JH1
Kim, DH1

Other Studies

1 other study available for mecamylamine and Ischemic Attack, Transient

ArticleYear
Neuroprotective effect of the ethanol extract of Artemisia capillaris on transient forebrain ischemia in mice via nicotinic cholinergic receptor.
    Chinese journal of natural medicines, 2018, Volume: 16, Issue:6

    Topics: Acetylcholinesterase; Animals; Artemisia; Cell Death; Cholinergic Antagonists; Disease Models, Anima

2018